|
Median age (upper quartile, lower quartile)
|
7.5 years (5.5, 9)
|
|---|
|
Symptoms
|
|
Nasal discharge
|
57 (72%)
|
|
Sneezing
|
83 (93%)
|
|
Nasal obstruction
|
70 (78%)
|
|
Nasal itching
|
56 (63%)
|
|
Watery itchy eyes
|
|
Diagnosis: aeroallergen sensitisation
|
|
SPT done
|
68 (76%)
|
|
1 or more positive SPT
|
60 (88%)
|
|
Specific IgE done
|
45 (50%)
|
|
SPT or specific IgE done
|
76 (85%)
|
|
Classification of AR
|
|
Intermittent
|
29 (33%)
|
|
Mild
|
20 (69%)
|
|
Moderate-severe
|
9 (31%)
|
|
Persistent
|
60 (67%)
|
|
Mild
|
28 (47%)
|
|
Moderate-severe
|
32 (53%)
|
|
Asthma management (GINA stage)
|
|
Stage 1
|
3 (4%)
|
|
Stage 2
|
24 (27%)
|
|
Stage 3
|
43 (48%)
|
|
Stage 4/5
|
18 (20%)
|
|
Leukotriene receptor antagonist
|
65 (73%)
|
|
AR treatment
|
|
No treatment
|
20 (23%)
|
|
Intermittent treatment
|
55 (61%)
|
|
Regular treatment
|
14 (16%)
|
- HDM house dust mite, SPT skin prick test, IgE immunoglobulin E, AR allergic rhinitis
